340B Drug Pricing Program
The Health Resources and Services Administration last week directed Sanofi to cease implementation of its 340B rebate proposal immediately and to inform HRSA of its plans no later than Dec. 20 in order to provide adequate notice to covered entities.
AHA 340B Advocacy Alliance Bulletin for December 16, 2024.
The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023. These increases led to $815 million incremental added costs for U.S. payers.
AHA urges 340B members to complete a brief survey to help the association understand how a 340B rebate model — such as the one Johnson & Johnson sought to implement this year — would impact 340B member hospitals.
As the largest rural hospital in Eastern Kentucky, UK St. Claire is part of an integrated health system serving as the primary provider across 11 counties in the region and caring for 170,000 patients annually.
340B Advocacy Alliance Bulletin for December 3, 2024.
AHA 340B Advocacy Alliance Bulletin - December 3, 2024.
The AHA Nov. 15 filed friend-of-the-court briefs in the U.S. Court of Appeals for the 5th Circuit in support of an earlier denial by the U.S. District Court for the Southern District of Mississippi of preliminary injunctions sought by Novartis and PhRMA against enforcement of the state's 340B…
AHA, others challenge Novartis in court filings to defend Mississippi’s 340B contract pharmacy law .
AHA, others challenge PhRMA in court filings to defend Mississippi’s 340B contract pharmacy law.